The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Mechanisms of resistance to cisplatin and carboplatin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–217 of 217
Ruan, H.-Y., Masuda, M., Ito, A., Umezawa, K., Nakashima, T., Yasumatsu, R., Kuratomi, Y., Yamamoto, T., Weinstein, I. B., & Komune, S. (2005) · Head & Neck · doi:10.1002/hed.20304 · Cited by 25
Zhang, P., Gao, W., Li, H., Reed, E., & Chen, F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.007 · Cited by 24
Distefano, M., Ferrandina, G., Smaniotto, D., Margariti, P. A., Zannoni, G., Macchia, G., Manfredi, R., Mangiacotti, M. G., Cellini, N., & Scambia, G. (2004) · Oncology · doi:10.1159/000080995 · Cited by 24
Olivero, M., Ruggiero, T., Saviozzi, S., Rasola, A., Coltella, N., Crispi, S., Cunto, F. D., Calogero, R., & Renzo, M. F. D. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0013 · Cited by 24
The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer
Gregorc, V. (2003) · Lung Cancer · doi:10.1016/j.lungcan.2003.07.003 · Cited by 24
Lu, Y., Yeh, P.-Y., Chuang, S., Gao, M., Kuo, M., & Cheng, A. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06453 · Cited by 22
Loss of p73 Induction in a Cisplatin-Resistant Bladder Cancer Cell Line
Ono, Y., Nonomura, N., Harada, Y., Fukui, T., Tokizane, T., Sato, E., Nakayama, M., Nishimura, K., Takahara, S., & Okuyama, A. (2001) · Molecular Urology · doi:10.1089/109153601750124267 · Cited by 20
Pharmacological Modulation of the Heat Shock Response
Sőti, C., & Csermely, P. (2005) · Springer eBooks · doi:10.1007/3-540-29717-0_17 · Cited by 19
The role of P-glycoprotein in human gastric cancer xenografts in response to chemotherapy.
Monden, N., Abe, S., Hishikawa, Y., Yoshimura, H., Kinugasa, S., Dhar, D. K., Tachibana, M., & Nagasue, N. (1999) · PubMed · Cited by 18
Fricke, E., Hermannstädter, C., Keller, G., Fuchs, M., Brunner, I., Busch, R. M., Höfler, H., Becker, K., & Luber, B. (2004) · Oncology · doi:10.1159/000077442 · Cited by 18
A molecular cytogenetic approach to studying platinum resistance
Hiorns, L. R., Seckl, M. J., Paradinas, F. J., Sharp, S. Y., Skelton, L., Brunström, G., Newlands, E. S., Kèlland, L. R., & Leyland-Jones, B. (1999) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(99)00140-3 · Cited by 16
Down-Regulation and Altered Localization of γ-Catenin in Cisplatin-Resistant Adenocarcinoma Cells
Liang, X., Shen, D., & Gottesman, M. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1217 · Cited by 16
Guida, M., Ravaioli, A., Chiarion‐Sileni, V., Romanini, A., Labianca, R., Freschi, A., Brugnara, S., CASAMASSIMA, A., Lorusso, V., Nanni, O., et al. (2003) · Journal of Translational Medicine · doi:10.1186/1479-5876-1-13 · Cited by 16
Induction of heat shock protein 70 in drug-resistant cells by anticancer drugs and hyperthermia.
Brozović, A., Šimaga, Š., & Osmak, M. (2001) · PubMed · Cited by 14
Molecular alterations of cells resistant to platinum drugs: Role of PKCα
Righetti, S. C., Perego, P., Carenini, N., Corna, E., Bo, L. D., Cedrola, S., Porta, C. A. M. L., & Zunino, F. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.12.007 · Cited by 13
Yu, J., Bicher, A., Ma, Y. K., Bostick-Bruton, F., & Reed, E. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00390-0 · Cited by 12
Increased BNip3 and decreased mutant p53 in cisplatin-sensitive PDT-resistant HT29 cells
Zacal, N., Espiritu, M., Singh, G., & Rainbow, A. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.213 · Cited by 12
Cited by
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Platinum-based drugs: past, present and future
Dilruba, S., & Kalayda, G. V. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-2976-z · Cited by 906
Platinum Resistance: The Role of DNA Repair Pathways
Martin, L. P., Hamilton, T. C., & Schilder, R. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2238 · Cited by 751
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Anticancer Activity of Metal Complexes: Involvement of Redox Processes
Jungwirth, U., Kowol, C. R., Keppler, B. K., Hartinger, C. G., Berger, W., & Heffeter, P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3663 · Cited by 554
Metadata
- Authors
- Stewart, D. J.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 63
- Issue
- 1
- Pages
- 12-31
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2058977958
- Cited by
- 631
- References
- 217
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.